A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants

Digoxin will be administered together with Rosuvastatin as a drug cocktail as specified for the respective period

Divarasib will be administered in combination with Digoxin and Rosuvastatin as specified for the respective period

Rosuvastatin will be administered together with Digoxin as a drug cocktail as specified for the respective period